Philadelphia-positive metaphases in the marrow after bone marrow transplantation for chronic granulocytic leukemia-Reference-Cited by-同舟云学术

Philadelphia-positive metaphases in the marrow after bone marrow transplantation for chronic granulocytic leukemia

Published:1986-06 Issue:2 Volume:22 Page:199-204
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Apperley Jane F.,Rassool Feyruz,Parreira Antonio,Geary Colin G.,Harrison Christine,Stansfield Derek,Goldman John M.

Publisher

Wiley

Subject

Hematology

Reference14 articles.

1. THE MOLECULAR BIOLOGY OF CHRONIC MYELOGENOUS LEUKAEMIA

2. ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA

3. BONE MARROW TRANSPLANTATION: A REVIEW OF DELAYED COMPLICATIONS

4. : “Chromosomes in Human Cancer and Leukemia.” New York: Elsevier North-Holland, 1980.

5. : The use of monoclonal antibodies to characterize human natural killer cell ontogeny and function. In (eds): “Monoclonal Antibodies–Probes for the Study of Autoimmunity and Immunodeficiency.” Orlando, FL: Academic Press, 1983, pp 97–113.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetic follow-up of 100 patients submitted to bone marrow transplantation for Philadelphia chromosome-positive chronic myeloid leukemia: Cooperative Study Group on Chromosomes in Transplanted Patients;European Journal of Haematology;2009-04-24

2. Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease;European Journal of Haematology;2009-04-24

3. Bone marrow transplantation for chronic myeloid leukaemia;Hematological Oncology;2006-10-13

4. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy;British Journal of Haematology;2000-10

5. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy;British Journal of Haematology;2000-10